296 related articles for article (PubMed ID: 10589905)
1. Nationwide survey in Italy of treatment of Streptococcus pyogenes pharyngitis in children: influence of macrolide resistance on clinical and microbiological outcomes. Artemis-Italy Study Group.
Varaldo PE; Debbia EA; Nicoletti G; Pavesio D; Ripa S; Schito GC; Tempera G
Clin Infect Dis; 1999 Oct; 29(4):869-73. PubMed ID: 10589905
[TBL] [Abstract][Full Text] [Related]
2. High macrolide resistance in Streptococcus pyogenes strains isolated from children with pharyngitis in China.
Liu X; Shen X; Chang H; Huang G; Fu Z; Zheng Y; Wang L; Li C; Liu L; Shen Y; Yang Y
Pediatr Pulmonol; 2009 May; 44(5):436-41. PubMed ID: 19360846
[TBL] [Abstract][Full Text] [Related]
3. Erythromycin resistance in Streptococcus pyogenes in Italy.
Bassetti M; Manno G; Collidà A; Ferrando A; Gatti G; Ugolotti E; Cruciani M; Bassetti D
Emerg Infect Dis; 2000; 6(2):180-3. PubMed ID: 10756153
[TBL] [Abstract][Full Text] [Related]
4. Oral antimicrobial susceptibilities of Streptococcus pyogenes recently isolated in five countries.
Bandak SI; Turnak MR; Allen BS; Bolzon LD; Preston DA
Int J Clin Pract; 2000 Nov; 54(9):585-8. PubMed ID: 11220986
[TBL] [Abstract][Full Text] [Related]
5. [Isolated susceptibility of Streptococcus pyogenes to 3 macrolides].
Sakran W; Raz R; Colodner R; Keness Y
Harefuah; 1997 Nov; 133(9):365-6, 414. PubMed ID: 9418339
[TBL] [Abstract][Full Text] [Related]
6. [Emergence of macrolide resistant Streptococcus pyogenes strains in pediatric patients in France].
Mariani-Kurkdjian P; Doit C; Deforche D; Brahimi N; Francois M; Van den Abbeele T; Bingen E
Pathol Biol (Paris); 2004 Oct; 52(8):489-92. PubMed ID: 15465270
[TBL] [Abstract][Full Text] [Related]
7. Macrolide prescriptions and erythromycin resistance of Streptococcus pyogenes.
Gagliotti C; Nobilio L; Milandri M; Moro ML;
Clin Infect Dis; 2006 Apr; 42(8):1153-6. PubMed ID: 16575736
[TBL] [Abstract][Full Text] [Related]
8. Macrolide-resistant Streptococcus pyogenes in the United States, 2002-2003.
Richter SS; Heilmann KP; Beekmann SE; Miller NJ; Miller AL; Rice CL; Doern CD; Reid SD; Doern GV
Clin Infect Dis; 2005 Sep; 41(5):599-608. PubMed ID: 16080080
[TBL] [Abstract][Full Text] [Related]
9. Macrolide therapy of group A streptococcal pharyngitis: 10 days of macrolide therapy (clarithromycin) is more effective in streptococcal eradication than 5 days (azithromycin).
Kaplan EL; Gooch III WM; Notario GF; Craft JC
Clin Infect Dis; 2001 Jun; 32(12):1798-802. PubMed ID: 11360224
[TBL] [Abstract][Full Text] [Related]
10. [Comparative in vitro activity of new oral macrolides against Streptococcus pyogenes strains].
Prado V; Romero J; Herrera N; Marinkovic K; Bustos R
Rev Med Chil; 1993 Oct; 121(10):1128-34. PubMed ID: 8191116
[TBL] [Abstract][Full Text] [Related]
11. Decline in macrolide resistance rates among Streptococcus pyogenes causing pharyngitis in children isolated in Italy.
Gherardi G; Petrelli D; Di Luca MC; Pimentel de Araujo F; Bernaschi P; Repetto A; Bellesi J; Vitali LA
Eur J Clin Microbiol Infect Dis; 2015 Sep; 34(9):1797-802. PubMed ID: 26024763
[TBL] [Abstract][Full Text] [Related]
12. Macrolide resistance in group A beta haemolytic Streptococcus isolated from outpatient children in Latvia.
Zavadska D; Bērziņa D; Drukaļska L; Pugacova N; Miklasevics E; Gardovska D
APMIS; 2010 May; 118(5):366-70. PubMed ID: 20477812
[TBL] [Abstract][Full Text] [Related]
13. Defining the optimum treatment regimen for azithromycin in acute tonsillopharyngitis.
Cohen R
Pediatr Infect Dis J; 2004 Feb; 23(2 Suppl):S129-34. PubMed ID: 14770076
[TBL] [Abstract][Full Text] [Related]
14. Streptococcus pyogenes collected in Torino (northwest Italy) between 1983 and 1998: survey of macrolide resistance and trend of genotype by RAPD.
Avanzini C; Bosio K; Volpe G; Dotti G; Savoia D
Microb Drug Resist; 2000; 6(4):289-95. PubMed ID: 11272257
[TBL] [Abstract][Full Text] [Related]
15. [Antibiotic sensitivity of Streptococcus pyogenes in pediatrics].
Gené A; González-Cuevas A; Juncosa T; Luaces C; Latorre C
Enferm Infecc Microbiol Clin; 1998; 16(6):272-4. PubMed ID: 9763744
[TBL] [Abstract][Full Text] [Related]
16. [Susceptibility of Streptococcus pyogenes isolates from pharyngeal exudates in Cordoba (Spain)].
Gordillo RM; Lacasa MJ; Ibarra A; Rodríguez F; Casal M
Rev Esp Quimioter; 2003 Mar; 16(1):58-60. PubMed ID: 12750758
[TBL] [Abstract][Full Text] [Related]
17. Acute streptococcal pharyngitis in pediatric medicine: current issues in diagnosis and management.
Shulman ST
Paediatr Drugs; 2003; 5 Suppl 1():13-23. PubMed ID: 14632102
[TBL] [Abstract][Full Text] [Related]
18. [Dirithromycin, a new antibiotic in the treatment of pharyngeal inflammation].
Riazantsev SV; Kosenko VA; Vlasova VV; Volkova VV
Vestn Otorinolaringol; 1995; (5):40-3. PubMed ID: 7502454
[TBL] [Abstract][Full Text] [Related]
19. Bacteriological and clinical efficacy of various antibiotics used in the treatment of streptococcal pharyngitis in Italy. An epidemiological study.
Rondini G; Cocuzza CE; Cianflone M; Lanzafame A; Santini L; Mattina R
Int J Antimicrob Agents; 2001 Jul; 18(1):9-17. PubMed ID: 11463521
[TBL] [Abstract][Full Text] [Related]
20. Susceptibility of Streptococcus pyogenes to two macrolides in northern Israel.
Sakran W; Raz R; Chazan B; Koren A; Colodner R
Int J Antimicrob Agents; 2004 May; 23(5):517-9. PubMed ID: 15120735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
